Southlake Health has selected the Philips Ambition X MR with BlueSeal technology — a helium-free 1...
NEWS
uniQure’s AMT-130 Demonstrates Statistically Significant 75 %...
uniQure has announced positive topline results from its pivotal Phase I/II trial of AMT-130 for the...
Pioneering TIL Therapy Delivered for Metastatic Lung Cancer at...
HCA Healthcare UK has delivered its first Tumour-Infiltrating Lymphocyte (TIL) therapy for a...
Lilly launches TuneLab to accelerate AI-driven drug discovery...
Eli Lilly and Company has launched Lilly TuneLab, an artificial intelligence and machine learning...